# To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men

> **NCT01707537** · PHASE1 · COMPLETED · sponsor: **EuBiologics Co.,Ltd** · enrollment: 20 (actual)

## Conditions studied

- Prevention Harmful Effects

## Interventions

- **BIOLOGICAL:** Euvichol

## Key facts

- **NCT ID:** NCT01707537
- **Lead sponsor:** EuBiologics Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01707537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01707537, "To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01707537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*